Sort   by:  
 Page size 
UnknownEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219 | biostudies-literature
UnknownCompeting biomedical HIV prevention strategies: potential cost-effectiveness of HIV vaccines and PrEP in Seattle, WA.
Not available
S-EPMC6689690 | biostudies-literature
UnknownSafety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Not available
S-EPMC8220996 | biostudies-literature
UnknownFinal Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.
Not available
S-EPMC8849184 | biostudies-literature
UnknownLower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02.
Not available
S-EPMC4936641 | biostudies-literature
UnknownDiscovery and Optimization of a Synthetic Class of Nectin-4-Targeted CD137 Agonists for Immuno-oncology.
Not available
S-EPMC9340768 | biostudies-literature
UnknownPredictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.
Not available
S-EPMC4121165 | biostudies-literature
UnknownIgG and Fc Receptor Genetic Variation Associates With Functional Antibody Responses in a DNA and Protein Candidate HIV Vaccine Trial.
Not available
S-EPMC12818096 | biostudies-literature
UnknownOral tolerance to systemic vaccination remains intact without RORγt expression in regulatory T cells.
Not available
S-EPMC10730369 | biostudies-literature
UnknownBenign ethnic neutropenia in a South African population, and its association with HIV acquisition and adverse event reporting in an HIV vaccine clinical trial.
Not available
S-EPMC7822320 | biostudies-literature
Sort   by:  
 Page size